In preclinical RA, ACPA+ individuals have decreased T regulatory (Treg) cell levels and a shift of CD4+ T cells towards pro-inflammatory subsets, in particular T helper (Th) 2 cells (53, 167). Here, PRTN3 is linked to rheumatoid arthritis.